Published

Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neurology
Date: 2024-04-09
Source: OpenAlex
DOI: 10.1212/wnl.0000000000206718
PubMed: Unavailable

Authors

Tina Singh Dipa Patel Kasey Bishop Rhea Shishodia Sadeepa Bulathsinhala

Watch author

Derived topics and classifications

psilocybin Addiction Mechanism of Action Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)2024-04-09

Related papers

Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-05-01 Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARASAIMSARA Journal · 2026-06-15 Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-05 α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07 Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health SymptomsJournal of Drug Issues · 2026-07-01 Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-29 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28